Supernus Pharmaceuticals IncAdd to My Watchlist

SUPN:USNASDAQ GMIndustry: Medical-Drugs
  • 25.35
  • 0.25  1.00%
    Today's Change
  • 25.10
    Previous Close
  • Today
    52 Week Low - High
8:10 pm ET 2/23/2017
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding50 million
Market Cap$1 billion
Return on Equity ttm59.19%
Last DividendSUPN:US does not pay a dividend
EPS: Year Actual ttm0.762
EPS: Year Est. 12/16 ttm1.222
EPS: Quarterly Actual 9/16 0.37
EPS: Quarterly Est. 12/16 0.26
Price/Earnings ttm33.25
Relative Price/Earnings1.530
Earnings Growth Rate-36.17
Company Description
Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company. The Company develops and markets proprietary drugs for the treatment of central nervous system diseases and disorders. Supernus has developed a portfolio of clinical stage drugs to address neurological and psychological problems such as epilepsy, conduct disorder, Parkinson's disease, ADHD, depression and anxiety.
Revenue$144 million
Net Income$14 million
Total Assets$189 million

Latest Headlines

No news available.


    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now


    Not Registered?

    Get complete access to The Washington Post online - it's FREE!